BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coleman CN, Eke I, Makinde AY, Chopra S, Demaria S, Formenti SC, Martello S, Bylicky M, Mitchell JB, Aryankalayil MJ. Radiation-induced Adaptive Response: New Potential for Cancer Treatment. Clin Cancer Res 2020;26:5781-90. [PMID: 32554542 DOI: 10.1158/1078-0432.CCR-20-0572] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Chopra S, Shankavaram U, Bylicky M, Dalo J, Scott K, Aryankalayil MJ, Coleman CN. Profiling mRNA, miRNA and lncRNA expression changes in endothelial cells in response to increasing doses of ionizing radiation. Sci Rep 2022;12:19941. [DOI: 10.1038/s41598-022-24051-6] [Reference Citation Analysis]
2 Kong Y, Zhao X, Xu M, Pan J, Ma Y, Zou L, Peng Q, Zhang J, Su C, Xu Z, Zhou W, Peng Y, Yang J, Zhou C, Li Y, Guo Q, Chen G, Wu H, Xing P, Zhang L. PD-1 Inhibitor Combined With Radiotherapy and GM-CSF (PRaG) in Patients With Metastatic Solid Tumors: An Open-Label Phase II Study. Front Immunol 2022;13:952066. [DOI: 10.3389/fimmu.2022.952066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Buchsbaum JC, Espey MG, Obcemea C, Capala J, Ahmed M, Prasanna PG, Vikram B, Hong JA, Teicher B, Aryankalayil MJ, Bylicky MA, Coleman CN. Tumor Heterogeneity Research and Innovation in Biologically Based Radiation Therapy From the National Cancer Institute Radiation Research Program Portfolio. J Clin Oncol 2022;:JCO2102579. [PMID: 35245101 DOI: 10.1200/JCO.21.02579] [Reference Citation Analysis]
4 Eke I, Aryankalayil MJ, Bylicky MA, Makinde AY, Liotta L, Calvert V, Petricoin EF, Graves EE, Coleman CN. Radiotherapy alters expression of molecular targets in prostate cancer in a fractionation- and time-dependent manner. Sci Rep 2022;12:3500. [PMID: 35241721 DOI: 10.1038/s41598-022-07394-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 López-Nieva P, González-Vasconcellos I, González-Sánchez L, Cobos-Fernández MA, Ruiz-García S, Sánchez Pérez R, Aroca Á, Fernández-Piqueras J, Santos J. Differential molecular response in mice and human thymocytes exposed to a combined-dose radiation regime. Sci Rep 2022;12:3144. [PMID: 35210498 DOI: 10.1038/s41598-022-07166-8] [Reference Citation Analysis]
6 van Genugten EAJ, Weijers JAM, Heskamp S, Kneilling M, van den Heuvel MM, Piet B, Bussink J, Hendriks LEL, Aarntzen EHJG. Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy. Front Oncol 2021;11:786089. [PMID: 35070990 DOI: 10.3389/fonc.2021.786089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Sato A, Kraynak J, Marciscano AE, Galluzzi L. Radiation therapy: An old dog learning new tricks. Radiation Oncology and Radiotherapy Part A 2022. [DOI: 10.1016/s0091-679x(22)00139-x] [Reference Citation Analysis]
8 Read GH, Bailleul J, Vlashi E, Kesarwala AH. Metabolic response to radiation therapy in cancer. Mol Carcinog 2021. [PMID: 34961986 DOI: 10.1002/mc.23379] [Reference Citation Analysis]
9 Stati G, Passaretta F, Gindraux F, Centurione L, Di Pietro R. The Role of the CREB Protein Family Members and the Related Transcription Factors in Radioresistance Mechanisms. Life (Basel) 2021;11:1437. [PMID: 34947968 DOI: 10.3390/life11121437] [Reference Citation Analysis]
10 Petroni G, Cantley LC, Santambrogio L, Formenti SC, Galluzzi L. Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer. Nat Rev Clin Oncol 2021. [PMID: 34819622 DOI: 10.1038/s41571-021-00579-w] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 17.0] [Reference Citation Analysis]
11 Das S, Mahapatra E, Biswas S, Roy M, Mukherjee S. Emerging Role of Aurora A in Radioresistance: A Comprehensive Review. EMJ Oncol 2021. [DOI: 10.33590/emjoncol/20-00251] [Reference Citation Analysis]
12 Aryankalayil MJ, Martello S, Bylicky MA, Chopra S, May JM, Shankardass A, MacMillan L, Sun L, Sanjak J, Vanpouille-Box C, Eke I, Coleman CN. Analysis of lncRNA-miRNA-mRNA expression pattern in heart tissue after total body radiation in a mouse model. J Transl Med 2021;19:336. [PMID: 34364390 DOI: 10.1186/s12967-021-02998-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Liu C, Hirakawa H, Katsube T, Fang Y, Tanaka K, Nenoi M, Fujimori A, Wang B. Altered Induction of Reactive Oxygen Species by X-rays in Hematopoietic Cells of C57BL/6-Tg (CAG-EGFP) Mice. Int J Mol Sci 2021;22:6929. [PMID: 34203224 DOI: 10.3390/ijms22136929] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Nickoloff JA, Taylor L, Sharma N, Kato TA. Exploiting DNA repair pathways for tumor sensitization, mitigation of resistance, and normal tissue protection in radiotherapy. Cancer Drug Resist 2021;4:244-63. [PMID: 34337349 DOI: 10.20517/cdr.2020.89] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
15 Nakano K. Progress of molecular targeted therapy for head and neck cancer in clinical aspects. Mol Biomed 2021;2:15. [PMID: 35006440 DOI: 10.1186/s43556-021-00032-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Coleman CN, Buchsbaum JC, Prasanna PGS, Capala J, Obcemea C, Espey MG, Ahmed MM, Hong JA, Vikram B. Moving Forward in the Next Decade: Radiation Oncology Sciences for Patient-Centered Cancer Care. JNCI Cancer Spectr 2021;5:pkab046. [PMID: 34350377 DOI: 10.1093/jncics/pkab046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Demaria S, Guha C, Schoenfeld J, Morris Z, Monjazeb A, Sikora A, Crittenden M, Shiao S, Khleif S, Gupta S, Formenti SC, Vikram B, Coleman CN, Ahmed MM. Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose? J Immunother Cancer 2021;9:e002038. [PMID: 33827904 DOI: 10.1136/jitc-2020-002038] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 51.0] [Reference Citation Analysis]
18 Kong Y, Ma Y, Zhao X, Pan J, Xu Z, Zhang L. Optimizing the Treatment Schedule of Radiotherapy Combined With Anti-PD-1/PD-L1 Immunotherapy in Metastatic Cancers. Front Oncol 2021;11:638873. [PMID: 33859942 DOI: 10.3389/fonc.2021.638873] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
19 May JM, Bylicky M, Chopra S, Coleman CN, Aryankalayil MJ. Long and short non-coding RNA and radiation response: a review. Transl Res 2021;233:162-79. [PMID: 33582242 DOI: 10.1016/j.trsl.2021.02.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
20 Printz C. First person profile: C. Norman Coleman, MD. Cancer 2020;126:4267-4268. [DOI: 10.1002/cncr.33192] [Reference Citation Analysis]